"10.1371_journal.ppat.1003220","plos pathogens","2013-04-11T00:00:00Z","Daniela F Angelini; Barbara Serafini; Eleonora Piras; Martina Severa; Eliana M Coccia; Barbara Rosicarelli; Serena Ruggieri; Claudio Gasperini; Fabio Buttari; Diego Centonze; Rosella Mechelli; Marco Salvetti; Giovanna Borsellino; Francesca Aloisi; Luca Battistini","Neuroimmunology Unit, Fondazione Santa Lucia, (I.R.C.C.S.), Rome, Italy; Department of Cell Biology and Neuroscience, Istituto Superiore di Sanità, Rome, Italy; Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy; Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy; Department of Neurosciences, S Camillo Forlanini Hospital, Rome, Italy; Department of Neurosciences, University Tor Vergata, Rome, Italy; Centre for Experimental Neurological Therapies, S. Andrea Hospital, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy","Conceived and designed the experiments: D.F. Angelini, B. Serafini, E.M. Coccia, F. Aloisi, L. Battistini. Analyzed the data: D.F. Angelini, B. Serafini, M. Salvetti, E.M. Coccia, G. Borsellino, F. Aloisi, L. Battistini. Contributed reagents/materials/analysis tools: S. Ruggieri, C. Gasperini, F. Buttari, D. Centonze, R. Mechelli, M. Salvetti. Performed the experiments: D.F. Angelini, B. Serafini, E. Piras, M. Severa, B. Rosicarelli, G. Borsellino. Wrote the paper: D.F. Angelini, G. Borsellino, F. Aloisi, L. Battistini.","Marco Salvetti, MD, received lecture fees from Biogen-Dompé and research support from Bayer-Schering, Biogen-Dompé, Merck-Serono, Sanofi-Aventis. Claudio Gasperini, MD, has served as a consultant for Merck Serono and Biogen Idec, and has received speaker honoraria from Teva, Merck Serono, Bayer Shering and Biogec Idec. Diego Centonze, MD, is an Advisory Board member of Merck-Serono, Teva and Bayer Shering and received funding for travelling and speaker honoraria or consultation fees from Merck Serono, Teva, Novartis, Bayer Shering, Sanofi-Aventis and Biogen Idec. He is also an external expert consultant of the European Medicine Agency (EMA) and the principal investigator in clinical trials for Novartis, Merck Serono, Teva, Bayer Shering, Sanofi Aventis and Biogen Idec. The other authors have no competing interests to report. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.","2013","04","Daniela F Angelini","DFA",15,FALSE,1,1,1,1,TRUE,TRUE,TRUE,9,"3;5;6;8;9;11;13;14;15",TRUE
